These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 16927730)

  • 21. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention deficit hyperactivity disorder in preschool children.
    Greenhill LL; Posner K; Vaughan BS; Kratochvil CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):347-66, ix. PubMed ID: 18295150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (For).
    Isaacs D
    J Paediatr Child Health; 2006 Sep; 42(9):544-7. PubMed ID: 16925542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
    Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
    Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Better health care for children and adolescents with attention deficit hyperactivity disorder].
    Klasen H; Verhulst FC
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1723-5. PubMed ID: 16114286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention deficit/hyperactivity disorder: a review and update.
    Cormier E
    J Pediatr Nurs; 2008 Oct; 23(5):345-57. PubMed ID: 18804015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical recognition and management of adult attention deficit hyperactivity disorder.
    Craig C
    Nurse Pract; 1996 Nov; 21(11):101-6, 108. PubMed ID: 8933539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention deficit/hyperactivity disorder. A guide to diagnosis and treatment.
    Nemethy MA
    Adv Nurse Pract; 1997 Feb; 5(2):22-5, 29. PubMed ID: 9459862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.
    Pliszka S;
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):894-921. PubMed ID: 17581453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.
    Jensen PS
    Am J Manag Care; 2009 May; 15(5 Suppl):S129-40. PubMed ID: 19601688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach.
    Monastra VJ
    Int J Psychophysiol; 2005 Oct; 58(1):71-80. PubMed ID: 15927296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of children with ADHD: psychopedagogical program at school versus psychostimulant medication.
    Miranda A; Jarque S; Rosel J
    Psicothema; 2006 Aug; 18(3):335-41. PubMed ID: 17296053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting.
    Culpepper L; Mattingly G
    Postgrad Med; 2008 Sep; 120(3):16-26. PubMed ID: 18824822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.